Fundamental regulation mechanism of proteins discovered

The chemical nature of the switch was completely unknown

11-May-2021 - Germany

proteins perform a vast array of functions in the cell of every living organism with critical roles in almost every biological process. Not only do they run our metabolism, manage cellular signaling and are in charge of energy production, as antibodies they are also the frontline workers of our immune system fighting human pathogens like the coronavirus. In view of these important duties, it is not surprising that the activity of proteins is tightly controlled. There are numerous chemical switches that control the structure and, therefore, the function of proteins in response to changing environmental conditions and stress. The biochemical structures and modes of operation of these switches were thought to be well understood. So a team of researchers at the University of Göttingen were surprised to discover a completely novel, but until now overlooked, on/off switch that seems to be a ubiquitous regulatory element in proteins in all domains of life.

Kai Tittmann

Protein structure with the newly identified switch between a cysteine and lysine residue showing its structure and electron density. This discovery has wide-reaching implications for understanding and treating diseases.

The researchers investigated a protein from the human pathogen Neisseria gonorrhoeae that causes gonorrhea, a bacterial infection with over 100 million cases worldwide. This disease is typically treated with antibiotics but increasing rates of antibiotic resistance pose a serious threat. In order to identify new treatments, they studied the structure and mechanism of a protein that is a key player in carbon metabolism of the pathogen. Surprisingly, the protein can be switched on and off by oxidation and reduction (known as a “redox switch). The scientists suspected this was caused by a common and well-established “disulfide switch” formed between two cysteine amino acids. When they deciphered the X-ray structures of the protein in the “on” and “off” state at the DESY particle accelerator in Hamburg, Germany, they were hit by an even bigger surprise. The chemical nature of the switch was completely unknown: it is formed between a lysine and a cysteine amino acid with a bridging oxygen atom.

“I couldn’t believe my eyes,” says Professor Kai Tittmann, who led the study, when he remembers seeing the structure of the novel switch for the first time. “We thought initially that this must have formed artificially as a by-product of the experimental process as this chemical entity was unknown.” However, numerous repetitions of the experiments always gave the same result and an analysis of the protein structure database further disclosed that there are many other proteins that very likely possess this switch, which apparently escaped earlier detection as the resolution of the protein structure analysis was insufficient to detect it for certain. The researchers admit that good fortune was on their side because the crystals they measured allowed the protein structure to be determined at extremely high resolution, meaning the novel switch couldn’t be missed. “The extensive screening for high-quality protein crystals has really paid off, I couldn’t be happier,” says Marie Wensien, first author of the paper.

The researchers believe the discovery of the novel protein switch will impact the life sciences in numerous ways, for instance in the field of protein design. It will also open new avenues in medical applications and drug design. Many human proteins with established roles in severe diseases are known to be redox-controlled and the newly discovered switch is likely to play a central role in regulating their biological function as well.

Original publication

Other news from the department science

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?

Last viewed contents

Three dimensional force microscopy - Method of measuring forces of tumour cells as they migrate through connective tissue developed

Emerging psoriasis therapies go head-to-head with marketed drugs - Comparative efficacy data critical for higher uptake since psoriasis is not considered a life-threatening condition

Novo Nordisk opens new research centre in Seattle

Mechanism for DNA Invasion of Adenoviral Covid-19 Vaccines Discovered - Premature release of DNA activates anti-viral alarm systems

Mechanism for DNA Invasion of Adenoviral Covid-19 Vaccines Discovered - Premature release of DNA activates anti-viral alarm systems

Triple-threat cancer-fighting polymer capsules for guided drug delivery created

Triple-threat cancer-fighting polymer capsules for guided drug delivery created

Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells - New approach could dramatically improve the success rate of immune-cell therapies

Biogen Idec and Sobi Initiate Global Clinical Trials of Long-Lasting Hemophilia A and B Product Candidates in Children

Scientists identify a candidate gene for osteoporosis - Gene may underlie differences between African Americans and Caucasians

Stora Enso and Gasum to make renewable energy from wastewater in Sweden

A better route to benzocyclobutenes, sought-after buildingblocks for drugs - Scripps Research chemists devise a new, C-H activation-based method for the synthesis of BCBs

A better route to benzocyclobutenes, sought-after buildingblocks for drugs - Scripps Research chemists devise a new, C-H activation-based method for the synthesis of BCBs

CT Atlantic AG Announces Appointment of Michael Höcker to CEO - Cara Lerner joins CT Atlantic as COO

Rentschler Expands Single-Use Manufacturing Capacities